This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4rrn
From Proteopedia
(Difference between revisions)
| (2 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| + | |||
==8-Tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors== | ==8-Tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors== | ||
| - | <StructureSection load='4rrn' size='340' side='right' caption='[[4rrn]], [[Resolution|resolution]] 1.80Å' scene=''> | + | <StructureSection load='4rrn' size='340' side='right'caption='[[4rrn]], [[Resolution|resolution]] 1.80Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[4rrn]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4RRN OCA]. For a <b>guided tour on the structure components</b> use [ | + | <table><tr><td colspan='2'>[[4rrn]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4RRN OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4RRN FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=3UW:(4S,4AS,10AR)-2-AMINO-8-(2-FLUOROPYRIDIN-3-YL)-1-METHYL-3,4,4A,10A-TETRAHYDRO-2H-SPIRO[IMIDAZOLE-4,10-PYRANO[3,2-B]CHROMEN]-5(1H)-ONE'>3UW</scene>, <scene name='pdbligand=NI:NICKEL+(II)+ION'>NI</scene | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=3UW:(4S,4AS,10AR)-2-AMINO-8-(2-FLUOROPYRIDIN-3-YL)-1-METHYL-3,4,4A,10A-TETRAHYDRO-2H-SPIRO[IMIDAZOLE-4,10-PYRANO[3,2-B]CHROMEN]-5(1H)-ONE'>3UW</scene>, <scene name='pdbligand=NI:NICKEL+(II)+ION'>NI</scene></td></tr> |
| - | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4rrn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4rrn OCA], [https://pdbe.org/4rrn PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4rrn RCSB], [https://www.ebi.ac.uk/pdbsum/4rrn PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4rrn ProSAT]</span></td></tr> | |
| - | + | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
== Function == | == Function == | ||
| - | [ | + | [https://www.uniprot.org/uniprot/BACE1_HUMAN BACE1_HUMAN] Responsible for the proteolytic processing of the amyloid precursor protein (APP). Cleaves at the N-terminus of the A-beta peptide sequence, between residues 671 and 672 of APP, leads to the generation and extracellular release of beta-cleaved soluble APP, and a corresponding cell-associated C-terminal fragment which is later released by gamma-secretase.<ref>PMID:10677483</ref> <ref>PMID:20354142</ref> |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 18: | Line 17: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
| + | <div class="pdbe-citations 4rrn" style="background-color:#fffaf0;"></div> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[Beta secretase 3D structures|Beta secretase 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Homo sapiens]] |
| - | [[Category: Brown | + | [[Category: Large Structures]] |
| - | [[Category: Burkard | + | [[Category: Brown KD]] |
| - | [[Category: Cox | + | [[Category: Burkard M]] |
| - | [[Category: DeLisle | + | [[Category: Cox AA]] |
| - | [[Category: | + | [[Category: DeLisle RK]] |
| - | [[Category: | + | [[Category: Dutcher D]] |
| - | [[Category: Groneberg | + | [[Category: Geck Do MK]] |
| - | [[Category: Hunt | + | [[Category: Groneberg R]] |
| - | [[Category: Liao | + | [[Category: Hunt KW]] |
| - | [[Category: Liu | + | [[Category: Liao J]] |
| - | [[Category: Lyssikatos | + | [[Category: Liu X]] |
| - | [[Category: Newhouse | + | [[Category: Lyssikatos JP]] |
| - | [[Category: Otten | + | [[Category: Newhouse B]] |
| - | [[Category: Purkey | + | [[Category: Otten JN]] |
| - | [[Category: Rana | + | [[Category: Purkey HE]] |
| - | [[Category: Regal | + | [[Category: Rana S]] |
| - | [[Category: Rhodes | + | [[Category: Regal K]] |
| - | [[Category: Scearce-Levie | + | [[Category: Rhodes SP]] |
| - | [[Category: Siu | + | [[Category: Scearce-Levie K]] |
| - | [[Category: Smith | + | [[Category: Siu M]] |
| - | [[Category: Thomas | + | [[Category: Smith D]] |
| - | [[Category: Vigers | + | [[Category: Thomas AA]] |
| - | [[Category: Watts | + | [[Category: Vigers GPA]] |
| - | [[Category: Wright | + | [[Category: Watts RJ]] |
| - | + | [[Category: Wright AD]] | |
| - | + | ||
Current revision
8-Tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors
| |||||||||||
Categories: Homo sapiens | Large Structures | Brown KD | Burkard M | Cox AA | DeLisle RK | Dutcher D | Geck Do MK | Groneberg R | Hunt KW | Liao J | Liu X | Lyssikatos JP | Newhouse B | Otten JN | Purkey HE | Rana S | Regal K | Rhodes SP | Scearce-Levie K | Siu M | Smith D | Thomas AA | Vigers GPA | Watts RJ | Wright AD
